MicroRNA-23a-3p improves traumatic brain injury through modulating the neurological apoptosis and inflammation

Zhikun Li1, Ruijun Xu1, Xiaodong Zhu1

  • 1Department of Orthopedic Surgery, TongRen Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.

Insights

MicroRNAs (miRNAs) like miR-23a show promise in treating traumatic brain injury (TBI). Upregulating miR-23a reduces neuron apoptosis and inflammation, improving neurological function after TBI.

Area of Science:

  • Neuroscience
  • Molecular Biology

Background:

  • Secondary brain damage significantly impacts Traumatic Brain Injury (TBI) outcomes.
  • The precise mechanisms driving secondary brain damage are not fully understood.
  • MicroRNAs (miRNAs) are implicated in cellular processes relevant to TBI pathogenesis.

Purpose of the Study:

  • To investigate the role of specific miRNAs in neuron apoptosis and inflammation following TBI.
  • To identify potential miRNA-based therapeutic targets for TBI treatment.

Main Methods:

  • Differential gene expression analysis of miRNAs in a TBI mouse model (controlled cortical impact).
  • In vitro studies using etoposide-induced primary cortical neuron injury models.
  • Validation of miRNA targets and signaling pathway activation (AKT/mTOR).

Main Results:

  • miR-23a was identified as a key miRNA with suppressive effects on apoptosis and inflammation.
  • Upregulation of miR-23a improved neurological function, reduced neuron apoptosis, and inhibited neuroinflammation in TBI mice.
  • miR-23a directly targets PTEN, modulating the AKT/mTOR pathway and reducing caspase-3 activity and inflammatory mediator release in neurons.

Conclusions:

  • miR-23a plays a protective role against secondary brain damage in TBI.
  • Restoring miR-23a levels may represent a novel therapeutic strategy for TBI.
  • The miR-23a/PTEN/AKT/mTOR axis is a critical pathway in TBI pathogenesis and treatment.

Related Concept Videos